Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-021040
Filing Date
2025-08-05
Accepted
2025-08-05 16:31:31
Documents
2
Period of Report
2025-07-28

Document Format Files

Seq Description Document Type Size
1 form3-08052025_080827.html 3  
1 form3-08052025_080827.xml 3 1703
2 ex24-08052025_080833.htm EX-24 6555
  Complete submission text file 0001415889-25-021040.txt   9701
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103 WAYNE PA 19087
Business Address
Kolbeck Roland Wilhelm (Reporting) CIK: 0002076327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 251185483